HONG KONG – A leading Chinese biotech company has plans to sell almost half the shares of its vaccine manufacturing subsidiary and invest $30 million in a biopharmaceutical distributor.
Researchers from the Chinese Medical College of Soochow University and the Chinese Academy of Sciences in Shanghai have identified a new target for the treatment of chronic pain.
BOGOTA, Colombia – Cuban and Chinese authorities are working together to boost the island´s biotech production through a series of bilateral cooperation agreements that have been in place since 2001.
In its ongoing scrutiny of heparin producers, the FDA has added a Beijing firm to a growing list of companies that are on import alert due to concerns about the potential for contamination.
NEW DELHI – A recent acquisition by a leading Indian biotech company could spur drug development and clinical trials for treatments for brain and central nervous system diseases. The incidence of both ailments is on the rise.
NEW DELHI – India's drug pricing regulator has withdrawn a series of guidelines that capped prices of diabetes, cardiovascular disease and asthma drugs.
SHANGHAI – Sanofi SA, of Paris, has chosen a Shanghai address for its Asia Pacific R&D Hub. Its fifth hub, it will coordinate a complex research network across 12 Asian countries, and 50 collaborations pursuing the pharma's model of borderless, "open innovation."
HONG KONG – Japanese scientists have identified a potent cell signaling mediator that could represent an important universal therapeutic target molecule for the development of effective new treatments for multiple myeloma (MM).
SHANGHAI – European drug companies may find it hard to bend the ear of the Chinese government on their own. The country is large with numerous stakeholders to take into account as China undertakes its massive health care reform project.
RSS